Overview
This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).
Eligibility
Inclusion Criteria:
- Adult patients (≥ 18 years of age).
- Patient followed with a chronic liver disease.
- Adult patient able to give his written consent.
- For European sites: patient affiliated to the healthcare system.
Exclusion Criteria:
- Vulnerable patients.
- Patients with ascites.
- Patients with heart failure.
- Patients with acute hepatitis.
- Patients with biliary obstruction.